Study of the Vascularity of Uterine Septum Using Three Dimensional Power Doppler Ultrasound
NCT ID: NCT03792438
Last Updated: 2019-01-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2017-05-27
2018-11-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diagnostic Accuracy of Doppler Ultrasound and Role of Uterine Artery Doppler
NCT03530475
Three-dimensional Power Doppler in the Diagnosis of Endometrial Lesions in Patients With Postmenopausal Bleeding
NCT03543592
Ultrasound in Prediction of Operative Findings in Cesarean Section Among Placenta Accreta Cases
NCT03286998
Prediction of Response to IUCD Associated Menorrhagia Using Doppler
NCT03794895
IS Three d Power Doppler of the Endometrial and Subendometrial Regions Effective in Predicting Endometrial Implantation?
NCT04081870
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In women with uterine septum vascularity of the septum may affect obstetric performance.
Research question:
In women with uterine septum does vascularity of the septum affect obstetric outcome?
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transvaginal 3D Power Doppler Ultrasound
Samsung H60 ultrasound machine with 4-9 MHz volume transducer using VOCAL system and Histogram Facility
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Women with suspected or confirmed pregnancy.
* Women with active pelvic infection or old one.
* Women with abnormal uterine bleeding.
* Fibroids, adenomyosis or ovarian swelling.
18 Years
35 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams Maternity Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hesham Mohamed Mohamed Elnaggar
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mohamed I Amer, MD
Role: STUDY_CHAIR
Professor
Nashwa E Hassan, MD
Role: STUDY_DIRECTOR
Assistant Professor
Mortada E Ahmed, MD
Role: STUDY_DIRECTOR
Lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ain Shams University Maternity Hospital
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Hesham Mohamed Elnaggar
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.